|
Investec Limited Incorporated in the Republic of South Africa Registration number 1925/002833/06 JSE share code: INL NSX share code: IVD BSE share code: INVESTEC ISIN: ZAE000081949 |
Investec plc Incorporated in England and Wales Registration number 3633621 LSE share code: INVP JSE share code: INP ISIN: GB00B17BBQ50 |
(jointly "Investec")
As part of the dual listed company structure, Investec plc and Investec Limited notify both the London Stock Exchange and the JSE Limited of matters which are required to be disclosed under the Disclosure Guidance and Transparency Rules and the Listing Rules of the United Kingdom Listing Authority (the "UKLA") and/or the JSE Listing Requirements.
Accordingly, we advise of the following:
ADDITIONAL LISTING - INVESTEC PLC
Application has been made to the UK Listing Authority and the London Stock Exchange for an additional listing of 13,961,407 ordinary shares of GBP0.0002 each in the capital of Investec plc (the "New plc Ordinary Shares") to satisfy deferred non-cash awards made to qualifying employees as part of variable remuneration under the Investec 1 Limited Share Incentive Plan and the Investec plc Executive Incentive Plan 2013. The New plc Ordinary Shares will be issued at a price of GBP4.63 per share. The New plc Ordinary Shares will rank pari passu with the existing issued ordinary shares of Investec plc. Pursuant to the dual listed company structure, Investec plc has also applied to the JSE Limited for the admission to trading of the New plc Ordinary Shares.
It is expected that trading in the New plc Ordinary Shares will commence on 12 June 2019
Following the additional listings, the total number of issued ordinary shares will be 696,082,618 ordinary shares of GBP0.0002 each.
London and Johannesburg
10 June 2019
|
For further information, please contact:
David Miller Investec plc Company Secretary + 44 (0)207 597 4000
|
Niki van Wyk Investec Limited Company Secretary +27 (0) 11286 7000 |
Sponsor:
Investec Bank Limited
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
